Avantor Unveils Next-Generation Sterile Sampling Platform to Strengthen Quality Control in CGT Manufacturing
November 2025 — As the cell and gene therapy (CGT) landscape continues to expand, the need for robust aseptic monitoring and contamination control is growing rapidly. According to a recent industry r...
More+
Contact
Contact Us
More+
FDA Approves Novartis Gene Therapy Itvisma for Expanded SMA Patient Population
Washington, Nov 24, 2025 — The U.S. Food and Drug Administration (FDA) has approved Itvisma, a gene therapy developed by Novartis, for a broader group of patients with spinal muscular atrophy (SMA), ...
More+
_20251128152047.webp "Oncolytic Virus CDMO Market Enters Rapid Growth Phase, Expected to Surpass USD 1.7 Billion by 2035")
Oncolytic Virus CDMO Market Enters Rapid Growth Phase, Expected to Surpass USD 1.7 Billion by 2035
A newly released market report on November 26, 2025 indicates that the global oncolytic virus CDMO services market is entering a phase of accelerated growth. According to the report, the market is pro...
More+
Genentech to Present 46 Hematology Abstracts at ASH 2025, Including New AAV Gene Therapy and Oncology Data
South San Francisco, CA — November 3, 2025 — Biotech leader Genentech announced that it will present 46 abstracts, including 12 oral presentations, from its hematology portfolio at the upcoming ASH ...
More+
Regeneron and Tessera Therapeutics Partner to Develop in-Vivo Gene Editing Therapy TSRA-196 for Alpha-1 Antitrypsin Deficiency
December 1, 2025 — Regeneron Pharmaceuticals announced today a global collaboration with Tessera Therapeutics to develop and commercialize Tessera’s investigational in-vivo gene editing therapy TSRA...
More+
86 198 5711 6962 
info@hillgene.com 
English
_20260106165102.webp "First-of-Its-Kind Fentanyl Vaccine Prepares to Enter Human Clinical Trials")